Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser.

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparative split face study in which 30 patients with freckles are recruited.One side of the face will be treated with Q Switched (QS)KTP 532nm, and the other side will be treated with intradermal tranexamic acid (TXA).

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kasr El Aini Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Both genders

• Age group > 18years old.

Exclusion Criteria:

• Pregnant and lactating females.

• Keloid and scarring tendancy

• Usage of invasive or semi invasive procedures for treatment of freckles such as chemical peeling , dermaroller..etc. 2 months prior to the study.

• Oral Isotretinoin 6 months prior to the study.

• Active herpetic lesions.

• Any concurrent active skin disease within the treated area.

• Photosensitive skin conditions such as systemic lupus erythematous.

• History of delayed wound healing.

• Bleeding diathesis.

• Medical conditions such as autoimmune diseases.